Hepatocellular adenoma screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{ZAS}} | {{CMG}}; {{AE}} {{ZAS}} | ||
==Overview== | ==Overview== | ||
There is insufficient [[evidence]] to recommend routine [[Screening (medicine)|screening]] for | There is insufficient [[evidence]] to recommend routine [[Screening (medicine)|screening]] for hepatocellular adenoma. | ||
==Hepatocellular | ==Hepatocellular Adenoma Screening== | ||
There is insufficient [[evidence]] to recommend | There is insufficient [[evidence]] to recommend routine [[Screening (medicine)|screening]] for hepatocellular adenoma. | ||
==References== | ==References== | ||
Revision as of 18:26, 20 August 2019
|
Hepatocellular adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatocellular adenoma screening On the Web |
|
American Roentgen Ray Society Images of Hepatocellular adenoma screening |
|
Risk calculators and risk factors for Hepatocellular adenoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]
Overview
There is insufficient evidence to recommend routine screening for hepatocellular adenoma.
Hepatocellular Adenoma Screening
There is insufficient evidence to recommend routine screening for hepatocellular adenoma.